Medicine prize kicks off Nobel week
October 8, 2012 by Pia Ohlin in Other
The 2012 Nobel Prize season opens Monday with the award for medicine, marking the start of a week of announcements and speculation over who will collect the literature and peace prizes.
The medicine prize will be announced in Stockholm at 11:30 am (0930 GMT) at the earliest.
With the awards committees keeping mum on their choices, Nobel watchers are left to play a guessing game.
Swedish media have suggested the medicine prize could go to Japan's Shinya Yamanaka and Britain's John Gurdon for their research in nuclear reprogramming, a process that instructs adult cells to form early stem cells which can then be used to form any tissue type.
James Till of Canada could also be honoured for his related work on blood stem cells.
Other medicine fields cited as worthy of Nobel recognition this year are epigenetics, which studies how genes respond to their environment, and optogenetics, where researchers can turn on or off a nerve cell, for example in a fruit fly or a mouse, to reprogramme the brain.
Japanese media voiced hope Yamanaka was in with a chance, with the Nikkei business daily declaring he was a "sure" thing for a Nobel one day, but conceding it might not be this year.
"It's a matter of time," it said.
The winner of the Nobel Peace Prize, perhaps the most watched of the prestigious awards, will be revealed Friday in Oslo, and the five-member Norwegian Nobel committee has 231 nominees to choose from this year.
No clear frontrunner has emerged so far, although Coptic Christian Maggie Gobran of Egypt, dubbed the "Mother Teresa" of Cairo's slums, tops the list of one betting site with odds of 6.5-to-1.
The committee keeps the list of nominees a well-guarded secret, but those who are entitled to nominate candidates can disclose the names they have put forward so the list is known to include former US president Bill Clinton, ex-German chancellor Helmut Kohl, the EU and WikiLeaks suspect Bradley Manning.
The head of the Peace Research Institute of Oslo, Kristian Berg Harpviken, follows the work of the committee and each year publishes his own shortlist of possible winners.
It includes US political scientist Gene Sharp, an expert on non-violent revolution; Russian rights group Memorial and its founder Svetlana Gannushkina; and independent Russian media outlet Echo of Moscow and its chief editor Alexei Venediktov.
A Nigerian duo campaigning against the misuse of religion, Archbishop John Onaiyekan and Mohamed Sa'ad Abubakar, Sultan of Sokoto, are also on it, as is Myanmar President Thein Sein.
Afghan human rights activist, ex-minister and burka opponent Sima Samar is meanwhile also seen as a possible winner, as is Cuban human rights activist Oscar Elias Biscet.
The other closely-watched award is the literature prize, with the usual names being tossed around Stockholm's literary circles.
Among them are Chinese author Mo Yan, Japan's Haruki Murakami, Canadian short story writer Alice Munro, US authors Don DeLillo and Philip Roth, Somali novelist Nuruddin Farah and Egyptian writer Nawal el Saadawi.
The date has not been set for the literature prize announcement, although it is traditionally on a Thursday and could therefore come on October 11.
Much buzz has focused on the physics prize this year, to be announced Tuesday, after the discovery in July of a new fundamental particle believed to be the Higgs boson.
It is one of the biggest breakthroughs in the field of physics in the past half-century, and is widely considered Nobel prize-worthy research.
The chemistry prize will be announced on Wednesday, with Swedish Radio suggesting Svante Paeaebo of Sweden could win for his groundbreaking analysis of ancient DNA.
The economics prize, dominated by Americans over the years, will wind up the Nobel season on October 15.
Because of the economic crisis, the Nobel Foundation has slashed the prize sum to eight million Swedish kronor ($1.2 million, 930,000 euros) per award, down from the 10 million kronor awarded since 2001.
(c) 2012 AFP
-
Nobel Prizes honor a record 5 women in 2009
Dec 10, 2009 |
not rated yet |
0
-
Nobel winners pay tribute to deceased laureate
Dec 06, 2011 |
not rated yet |
0
-
Quantum physics is the focus of Nobel buzz
Oct 04, 2011 |
not rated yet |
0
-
'Narrow' Nobel Prize categories stir debate
Oct 01, 2010 |
not rated yet |
0
-
Nobel laureates receive 2011 prizes at Stockholm ceremony
Dec 11, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Early use of tracheostomy for mechanically ventilated patients not associated with improved survival
For critically ill patients receiving mechanical ventilation, early tracheostomy (within the first 4 days after admission) was not associated with an improvement in the risk of death within 30 days compared to patients who ...
Other
8 hours ago |
not rated yet |
0
Decisions to forgo life support may depend heavily on the ICU where patients are treated
The decision to limit life support in patients in the intensive care unit (ICU) appears to be significantly influenced by physician practices and/or the culture of the hospital, suggests new findings from researchers at the ...
Other
10 hours ago |
not rated yet |
0
People on higher incomes are happier with new knees
Knee replacement surgery is a very common procedure. However, it does not always resolve function or pain in all the recipients of new knees. A study by Robert Barrack, MD and his colleagues from the Washington University ...
Other
13 hours ago |
not rated yet |
0
New search engine finds rare diagnoses
Doctors are trained to think "common disease" when they meet patients in their practices, and as they rarely or never meet a rare disease, it often takes many years to reach the right diagnosis. A new search tool called FindZebra ...
Other
13 hours ago |
not rated yet |
0
Delayed transfer to the ICU increases risk of death in hospital patients
Delayed transfer to the intensive care unit (ICU) in hospitalized patients significantly increases the risk of dying in the hospital, according to a new study from researchers in Chicago.
Other
14 hours ago |
not rated yet |
0
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.